SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000038777-24-000023
Filing Date
2024-02-06
Accepted
2024-02-06 13:58:21
Documents
1

Document Format Files

Seq Description Document Type Size
1 reva23in.htm SC 13G 188693
  Complete submission text file 0000038777-24-000023.txt   190413
Mailing Address FRANKLIN RESOURCES INC ONE FRANKLIN PARKWAY SAN MATEO CA 94403
Business Address ONE FRANKLIN PARKWAY BUILDING 920/2, LEGAL-FRI SECRETARY SAN MATEO CA 94403 650-312-2000
FRANKLIN RESOURCES INC (Filed by) CIK: 0000038777 (see all company filings)

IRS No.: 132670991 | State of Incorp.: DE | Fiscal Year End: 0930
Type: SC 13G
SIC: 6282 Investment Advice
(CF Office: 02 Finance)

Mailing Address 1222 DEMONBREUN STREET SUITE 2000 NASHVILLE TN 37203
Business Address 1222 DEMONBREUN STREET SUITE 2000 NASHVILLE TN 37203 6157247755
Revance Therapeutics, Inc. (Subject) CIK: 0001479290 (see all company filings)

IRS No.: 770551645 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88023 | Film No.: 24599505
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)